Amgen reports a data breach in third-party cloud systems but expects no material impact on financials or operations.
Amgen revealed a cybersecurity breach affecting its third-party cloud systems, compromising proprietary data and patient health information. The company filed an 8-K with the SEC, stating it activated its cybersecurity response plan to contain the leak but does not anticipate a material financial impact.
The breach was detected in cloud-based systems, though Amgen confirmed its products, manufacturing, and financial reporting remain unaffected. The company continues to investigate the extent of the hackers’ access. This incident follows regulatory scrutiny over Tavneos, which generated $459m in 2025 amid concerns over clinical data integrity.
Amgen also recently approved a $74m investment, though details remain undisclosed. The company maintains the breach is unlikely to alter its financial condition or results.